2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide
C29H33Cl2N3O4S — CID 132694312
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide
2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide (PubChem CID 132694312) has the molecular formula C29H33Cl2N3O4S and a molecular weight of 590.57 g/mol. Its IUPAC name is 2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide.
Molecular Properties
| Compound Name | 2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide |
|---|---|
| PubChem CID | 132694312 |
| Molecular Formula | C29H33Cl2N3O4S |
| Molecular Weight | 590.57 g/mol |
| Exact Mass | 589.16 |
| IUPAC Name | 2-[(3,4-dichlorophenyl)methyl-[2-(2-ethyl-N-(4-methylphenyl)sulfonylanilino)acetyl]amino]-N-methylbutanamide |
| SMILES | CCc1ccccc1N(CC(=O)N(Cc1ccc(Cl)c(Cl)c1)C(CC)C(=O)NC)S(=O)(=O)c1ccc(C)cc1 |
| InChI | InChI=1S/C29H33Cl2N3O4S/c1-5-22-9-7-8-10-27(22)34(39(37,38)23-14-11-20(3)12-15-23)19-28(35)33(26(6-2)29(36)32-4)18-21-13-16-24(30)25(31)17-21/h7-17,26H,5-6,18-19H2,1-4H3,(H,32,36) |
| InChIKey | SIKDLSPVEPMMGZ-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 86.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 590.57 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 132694312 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.